Constellation Pharmaceuticals to Host Analyst/Investor Meeting at ASH to Discuss Updated Preliminary Data from the MANIFEST C...
02 Décembre 2019 - 5:00PM
Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a
clinical-stage biopharmaceutical company using its expertise in
epigenetics to discover and develop novel therapeutics, will host
an analyst/investor event and webcast on December 9 at 12:30 PM EST
in Salon 2 at the Rosen Centre Hotel in Orlando, Florida, in
conjunction with the annual meeting of the American Society of
Hematology.
The event will be webcast live and can be accessed on the
Investor Relations section of Constellation’s website at
http://ir.constellationpharma.com/events-and-presentations/events.
Analysts and investors may also access the event and participate in
the live question-and-answer session by dialing (877) 473-2077
(domestic) or (661) 378-9662 (international) and referring to
conference ID 7892044. A replay of the call will be available at
(855) 859-2056, (404) 537-3406 or (800) 585-8367.
About Constellation
Pharmaceuticals
Constellation Pharmaceuticals is a clinical-stage
biopharmaceutical company developing novel therapeutics that
selectively modulate gene expression to address serious unmet
medical needs in patients with cancer. The Company has a deep
understanding of how epigenetic and chromatin modifications in
cancer cells and in the tumor and immune microenvironment play a
fundamental role in driving disease progression and drug
resistance. Constellation is driving development of the BET
inhibitor CPI-0610 for the treatment of myelofibrosis as well as
the EZH2 inhibitors CPI-1205 and CPI-0209 for the treatment of
metastatic castration-resistant prostate cancer and other
cancers. The Company is also applying its broad research and
development capabilities to explore other novel targets that
directly and indirectly impact gene expression to fuel a
sustainable pipeline of innovative small-molecule product
candidates.
Contact
Ronald Aldridge Investor RelationsConstellation
Pharmaceuticals +1
617-714-0539ron.aldridge@constellationpharma.com
Lauren Arnold Media Relations MacDougall Biomedical
Communications +1 781-235-3060 larnold@macbiocom.com
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Constellation Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur